Clinical trial
Recovery From Amblyopia With Cholinesterase Inhibitors
NCT01584076 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recovery From Amblyopia With Cholinesterase Inhibitors
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- January 31, 2021
- Enrollment
- 18 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.